These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16886819)

  • 41. US aims to tighten rules on direct-to-consumer drug ads.
    Vastag B
    Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 43. New efforts to harmonise clinical evaluation.
    Donawa M
    Med Device Technol; 2006; 17(9):28, 30, 32. PubMed ID: 17240684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug advertising. GAO spurs advocates to urge FDA fast-track oversight of drug ads.
    AIDS Policy Law; 2006 Dec; 22(1):1, 4. PubMed ID: 17278241
    [No Abstract]   [Full Text] [Related]  

  • 45. Medical-device user instructions: the patient's need, the nurse's role.
    Kingsley PA; Backinger CL; Brady MW
    Home Healthc Nurse; 1995; 13(1):31-7. PubMed ID: 7860339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Device safety and effectiveness in the pediatric population: a US FDA perspective.
    Samuels-Reid J; Cope JU; Morrison AE
    Expert Rev Med Devices; 2009 Mar; 6(2):131-5. PubMed ID: 19298160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Avoiding surprises when implementing a single quality system.
    Donawa M
    Med Device Technol; 2009; 20(2):28, 30-1. PubMed ID: 19405340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complying with US and European change control requirements, Part I.
    Donawa ME
    Med Device Technol; 1997 Oct; 8(8):10-3. PubMed ID: 10174270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manufacturers of medical devices join the chorus of regulatory critics.
    Stein J
    Natl J (Wash); 1980 Sep; 12(38):1566-9. PubMed ID: 10298001
    [No Abstract]   [Full Text] [Related]  

  • 50. Medical device regulation: what a practicing dermatologist should know.
    Dang JM; Krause D; Felten RP; Luke MC
    Dermatol Ther; 2009; 22(3):241-5. PubMed ID: 19453348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDA on warpath for Google links.
    Osborne R
    Nat Biotechnol; 2009 May; 27(5):405. PubMed ID: 19430430
    [No Abstract]   [Full Text] [Related]  

  • 52. The future of medical device development in the United States.
    Utley JR
    ASAIO J; 1997; 43(1):1-4. PubMed ID: 9116342
    [No Abstract]   [Full Text] [Related]  

  • 53. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 54. Inconsistent government policies: why FDA off-label regulation cannot survive First Amendment review under Greater New Orleans.
    Hall RF; Sobotka E
    Food Drug Law J; 2007; 62(1):1-48. PubMed ID: 17444025
    [No Abstract]   [Full Text] [Related]  

  • 55. The Food and Drug Administration's evolving regulation of press releases: limits and challenges.
    Vodra WW; Cortez NG; Korn DE
    Food Drug Law J; 2006; 61(4):623-51. PubMed ID: 17180767
    [No Abstract]   [Full Text] [Related]  

  • 56. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW; Rice LG; Ambrose PJ
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract]   [Full Text] [Related]  

  • 57. Direct-to-consumer advertising of medical devices under scrutiny.
    Mitka M
    JAMA; 2008 Nov; 300(17):1985-6. PubMed ID: 18984880
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulating drug promotion on the Internet.
    Bannon L
    Food Drug Law J; 1999; 54(4):599-621. PubMed ID: 11824457
    [No Abstract]   [Full Text] [Related]  

  • 59. The US medical device bundling policy.
    Donawa M
    Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Auditing device clinical studies for US requirements.
    Donawa M
    Med Device Technol; 2007 Oct; 18(6):24-7. PubMed ID: 18078178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.